Clinical Trial Update: Clinical Verification of Peptide Biomarkers for Type 2 Diabetes Mellitus

View source ↗

Summary

Completed clinical trial evaluating peptide biomarkers for Type 2 diabetes mellitus conducted under sponsorship of the Beijing Institute of Technology.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Beijing Institute of Technology | Conditions: Diabetes Mellitus, Type 2 | Status: COMPLETED